https://lupushub.com daily 1 2026-04-03T17:37:57.638Z https://lupushub.com/types weekly 0.8 2025-02-07T10:55:00.000Z https://lupushub.com/types/systemic-lupus-erythematosus weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/types/cutaneous-lupus-erythematosus weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/types/lupus-nephritis weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/types/risk weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/therapeutics weekly 0.8 2025-02-07T10:55:00.000Z https://lupushub.com/therapeutics/immune-cell-targeted-therapies weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/therapeutics/car-therapy weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/therapeutics/anticytokine-therapies weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/therapeutics/immunoproteasome-inhibitor weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/therapeutics/immunosuppressive-agents weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/therapeutics/corticosteroids weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/therapeutics/enpatoran weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/therapeutics/ianalumab weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/therapeutics/belimumab-1 weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/therapeutics/antimalarials weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/therapeutics/telitacicept weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/therapeutics/itolizumab weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/therapeutics/rslv-132 weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/therapeutics/aspirin weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/therapeutics/caplacizumab weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/therapeutics/rontalizumab weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/therapeutics/blisibimod weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/therapeutics/fenebrutinib weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/therapeutics/sifalimumab weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/therapeutics/tabalumab weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/therapeutics/edratide weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/therapeutics/ustekinumab weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/therapeutics/vobarilizumab weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/therapeutics/evobrutinib weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/therapeutics/obexelimab weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/therapeutics/calcineurin-inhibitor weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/therapeutics/mycophenolate-1 weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/congresses weekly 0.8 2025-02-07T10:55:00.000Z https://lupushub.com/congresses/american-society-of-hematology weekly 0.7 2025-12-19T09:12:00.000Z https://lupushub.com/congresses/acr-convergence weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/congresses/eular weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/congresses/sleuro weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/congresses/iracon-2024 weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/congresses/era-2024 weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/congresses/aad weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/congresses/aplar weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/trials weekly 0.8 2025-02-07T10:55:00.000Z https://lupushub.com/trials/gardenia weekly 0.7 2026-03-04T15:53:00.000Z https://lupushub.com/trials/jasmine weekly 0.7 2026-03-04T15:56:00.000Z https://lupushub.com/trials/lilac weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/trials/amethyst weekly 0.7 2026-01-29T14:32:00.000Z https://lupushub.com/trials/tulip-sc weekly 0.7 2025-10-27T10:54:00.000Z https://lupushub.com/trials/carlysle weekly 0.7 2025-10-21T09:28:00.000Z https://lupushub.com/trials/nobility weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/trials/regency weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/trials/reset-sle weekly 0.7 2025-06-07T09:58:00.000Z https://lupushub.com/trials/care weekly 0.7 2025-06-07T09:58:00.000Z https://lupushub.com/trials/sleek weekly 0.7 2025-06-07T09:58:00.000Z https://lupushub.com/trials/palizade weekly 0.7 2025-10-21T09:28:00.000Z https://lupushub.com/trials/PHOENYCS GO weekly 0.7 2025-02-25T10:18:00.000Z https://lupushub.com/trials/paisley weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/trials/laser weekly 0.7 2025-06-07T09:58:00.000Z https://lupushub.com/trials/tulip-lte weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/trials/resolution weekly 0.7 2025-04-10T16:59:00.000Z https://lupushub.com/trials/bliss-believe weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/trials/gleam weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/trials/tulip-2 weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/trials/tulip-1 weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/trials/bliss-sc weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/trials/embrace weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/trials/bliss-76 weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/trials/bliss-52 weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/trials/muse weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/trials/aurora weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/trials/aura-lv weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/trials/alms weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/trials/equalise weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/trials/bliss-nea weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/trials/sle-brave-i weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/trials/sle-brave-ii weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/trials/rise weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/trials/poetyk-sle-2 weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/trials/poetyk-sle-1 weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/trials/mission weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/trials/bliss-ln weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/trials/lumina weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/trials/tulip-ln weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/expert-opinions weekly 0.8 2025-02-07T17:18:00.000Z https://lupushub.com/drug-updates weekly 0.8 2025-02-07T17:18:00.000Z https://lupushub.com/educational-resources weekly 0.8 2026-01-12T16:19:00.000Z https://lupushub.com/educational-resources/steering-committee-meetings weekly 0.7 2026-01-12T16:19:00.000Z https://lupushub.com/educational-resources/drugs-approvals weekly 0.7 2026-01-12T16:19:00.000Z https://lupushub.com/educational-resources/editorial-themes-and-reviews weekly 0.7 2026-01-12T16:19:00.000Z https://lupushub.com/educational-resources/guidelines weekly 0.7 2025-02-07T10:55:00.000Z https://lupushub.com/educational-resources/visual-abstracts weekly 0.7 2026-01-12T16:19:00.000Z https://lupushub.com/educational-resources/disease-overviews weekly 0.7 2026-01-12T16:19:00.000Z https://lupushub.com/medical-information/nipocalimab-granted-fda-fast-track-designation-for-sle monthly 0.9 2026-03-04T17:00:00.000Z https://lupushub.com/medical-information/lilac-phase-ii-post-hoc-analysis-litifilimab-skin-outcomes-in-cle monthly 0.9 2026-02-06T16:36:00.000Z https://lupushub.com/medical-information/litifilimab-granted-breakthrough-therapy-status-by-the-fda-for-cle monthly 0.9 2026-01-29T15:38:00.000Z https://lupushub.com/medical-information/tulip-sc-subcutaneous-anifrolumab-shows-efficacy-in-sle monthly 0.9 2026-01-23T11:11:00.000Z https://lupushub.com/medical-information/carlysle-phase-i-trial-obe-cel-for-severe-refractory-sle monthly 0.9 2026-02-11T15:02:00.000Z https://lupushub.com/medical-information/the-european-commission-approves-self-administered-subcutaneous-anifrolumab-for-adult-patients-with-sle monthly 0.9 2025-12-19T09:07:00.000Z https://lupushub.com/medical-information/obinutuzumab-receives-european-commission-approval-for-the-treatment-of-lupus-nephritis monthly 0.9 2025-12-10T17:00:00.000Z https://lupushub.com/medical-information/2025-acr-guideline-for-the-treatment-of-sle monthly 0.9 2025-11-26T14:45:00.000Z https://lupushub.com/medical-information/acr-2025-live-congress-feed monthly 0.9 2026-01-26T13:16:00.000Z https://lupushub.com/medical-information/positive-chmp-opinion-for-anifrolumab-subcutaneous-self-administration-for-adult-patients-with-sle monthly 0.9 2025-10-27T14:22:00.000Z https://lupushub.com/medical-information/sle-disease-modification-framework-delphi-consensus monthly 0.9 2025-11-04T15:09:00.000Z https://lupushub.com/medical-information/acr-2025-top-abstracts-whats-hot-in-lupus monthly 0.9 2025-10-22T08:46:00.000Z https://lupushub.com/medical-information/obinutuzumab-receives-us-fda-approval-for-the-treatment-of-lupus-nephritis monthly 0.9 2025-10-20T14:31:00.000Z https://lupushub.com/medical-information/phase-ii-sleek-trial-abbv-599-and-upadacitinib-monotherapy-in-sle monthly 0.9 2025-09-29T08:42:00.000Z https://lupushub.com/medical-information/guideline-adherence-in-the-management-of-lupus-key-challenges-and-potential-solutions monthly 0.9 2025-09-03T10:06:00.000Z https://lupushub.com/medical-information/2025-american-college-of-rheumatology-guidelines-for-the-treatment-of-sle monthly 0.9 2025-07-25T11:31:00.000Z https://lupushub.com/medical-information/eular2025-congress-coverage-real-world-studies-and-management-strategies monthly 0.9 2025-06-27T12:12:00.000Z https://lupushub.com/medical-information/eular2025-congress-coverage-phase-iii-trials monthly 0.9 2025-06-27T12:12:00.000Z https://lupushub.com/medical-information/eular2025-congress-coverage-from-the-lupus-hub monthly 0.9 2025-06-27T11:53:00.000Z https://lupushub.com/medical-information/belimumab-autoinjector-receives-us-fda-approval-for-use-in-pediatric-ln monthly 0.9 2025-06-25T14:04:00.000Z https://lupushub.com/medical-information/eular-2025-whats-hot-in-lupus monthly 0.9 2025-06-09T14:32:00.000Z https://lupushub.com/medical-information/tulip-lte-long-term-effect-of-anifrolumab-on-patient-reported-outcomes-in-sle monthly 0.9 2025-05-30T08:08:00.000Z https://lupushub.com/medical-information/consensus-recommendations-for-the-implementation-of-treat-to-target-strategies-in-sle monthly 0.9 2025-04-30T14:41:00.000Z https://lupushub.com/medical-information/fda-grants-fast-track-designation-to-allo-329-for-the-treatment-of-systemic-lupus-erythematosus monthly 0.9 2025-04-25T14:16:00.000Z https://lupushub.com/medical-information/regency-phase-iii-trial-obinutuzumab-for-lupus-nephritis monthly 0.9 2025-03-12T09:19:00.000Z https://lupushub.com/medical-information/phoenycs-go-phase-iii-trial-dapirolizumab-pegol-soc-vs-placebo-soc-in-sle monthly 0.9 2025-02-25T09:47:00.000Z https://lupushub.com/medical-information/management-of-lupus-nephritis-acr-2024-guidelines monthly 0.9 2026-01-12T16:20:00.000Z https://lupushub.com/medical-information/sequential-therapy-with-belimumab-and-rituximab-in-sle-results-from-the-phase-iii-bliss-believe-trial monthly 0.9 2024-12-20T12:31:00.000Z https://lupushub.com/medical-information/u-s-fda-grants-fast-track-designation-for-cd19-directed-car-t-cell-therapy-sc291 monthly 0.9 2024-12-04T10:57:00.000Z https://lupushub.com/medical-information/management-approach-for-refractory-sle-a-case-study monthly 0.9 2025-08-19T14:44:00.000Z https://lupushub.com/medical-information/integrating-type-2-symptoms-into-sle-management-strategies monthly 0.9 2025-08-19T14:43:00.000Z https://lupushub.com/medical-information/precision-medicine-in-systemic-lupus-erythematosus monthly 0.9 2025-07-31T11:02:00.000Z https://lupushub.com/medical-information/systematic-review-and-meta-analysis-of-mental-health-conditions-in-patients-with-sle monthly 0.9 2024-05-29T15:07:00.000Z https://lupushub.com/medical-information/venous-thromboembolism-in-patients-with-sle-long-term-incidence-risk-factors-and-outcomes monthly 0.9 2024-05-23T14:57:00.000Z https://lupushub.com/medical-information/what-are-the-management-techniques-for-refractory-antiphospholipid-syndrome monthly 0.9 2024-08-02T15:38:00.000Z https://lupushub.com/medical-information/immunomodulatory-mechanisms-of-anifrolumab-a-transcriptomic-and-proteomic-analysis-of-phase-iii-trials monthly 0.9 2025-05-14T14:59:00.000Z https://lupushub.com/medical-information/https-www-youtube-comwatchvl90utbm-ws4andfeatureyoutu-be monthly 0.9 2024-06-25T15:42:00.000Z https://lupushub.com/medical-information/belimumab-autoinjector-receives-u-s-fda-approval-for-use-in-pediatric-sle monthly 0.9 2024-05-22T08:31:00.000Z https://lupushub.com/medical-information/patient-reported-outcomes-in-neuropsychiatric-sle-post-hoc-analysis-of-four-phase-iii-trials-of-belimumab monthly 0.9 2024-05-10T11:47:00.000Z https://lupushub.com/medical-information/development-and-validation-of-slesis-r-for-prediction-of-serious-infection-in-patients-with-sle monthly 0.9 2024-05-10T08:17:00.000Z https://lupushub.com/medical-information/sle-das-as-a-disease-activity-measure-post-hoc-analyses-of-phase-ii-and-iii-trials-of-anifrolumab monthly 0.9 2024-05-03T09:08:00.000Z https://lupushub.com/medical-information/recommendations-for-integrating-physical-activity-and-exercise-in-the-management-of-sle monthly 0.9 2026-01-12T16:21:00.000Z https://lupushub.com/medical-information/lupus-low-disease-activity-state-in-patients-with-recent-onset-vs-established-sle monthly 0.9 2024-04-26T10:41:00.000Z https://lupushub.com/medical-information/povetacicept-an-enhanced-dual-baffapril-inhibitor-for-treatment-of-sle monthly 0.9 2025-08-19T13:43:00.000Z https://lupushub.com/medical-information/safety-and-efficacy-of-voclosporin-based-triple-immunosuppressive-therapy-in-lupus-nephritis monthly 0.9 2024-04-19T10:44:00.000Z https://lupushub.com/medical-information/safety-of-enpatoran-in-patients-with-active-slecle-results-from-a-phase-ib-study monthly 0.9 2024-04-17T10:12:00.000Z https://lupushub.com/medical-information/validation-of-childhood-lupus-low-disease-activity-state-definition monthly 0.9 2024-04-17T10:21:00.000Z https://lupushub.com/medical-information/safety-and-efficacy-of-itolizumab-in-lupus-nephritis-results-from-phase-ib-equalise-study monthly 0.9 2024-04-02T16:19:00.000Z https://lupushub.com/medical-information/tapering-steroids-in-modified-serologically-active-clinically-quiescent-patients-with-sle monthly 0.9 2024-03-28T16:38:00.000Z https://lupushub.com/medical-information/efficacy-and-safety-of-gut-microbiota-based-therapies-for-sle-and-ln monthly 0.9 2024-03-26T15:24:00.000Z https://lupushub.com/medical-information/association-between-history-of-vaccination-and-the-development-of-sle monthly 0.9 2024-03-20T12:58:00.000Z https://lupushub.com/medical-information/real-world-long-term-safety-and-efficacy-of-tacrolimus-final-analysis-of-the-trust-study monthly 0.9 2024-03-14T12:30:00.000Z https://lupushub.com/medical-information/efficacy-and-safety-of-rslv-132-in-patients-with-sle-a-phase-iia-trial monthly 0.9 2024-03-08T19:05:00.000Z https://lupushub.com/medical-information/role-of-smith-specific-regulatory-cells-in-the-management-of-lupus-nephritis monthly 0.9 2024-03-08T19:03:00.000Z https://lupushub.com/medical-information/utility-of-repeat-anti-dsdna-testing-in-patients-with-sle-smart-sle monthly 0.9 2024-03-06T14:02:00.000Z https://lupushub.com/medical-information/lfa-real-clinician-reported-outcome-as-an-effective-disease-activity-measure-for-systemic-lupus-erythematosus monthly 0.9 2024-03-01T11:24:00.000Z https://lupushub.com/medical-information/predictors-and-prevention-of-renal-flares-pooled-analysis-of-four-phase-iii-trials-of-belimumab monthly 0.9 2024-02-27T08:48:00.000Z https://lupushub.com/medical-information/impact-of-mycophenolate-mofetil-discontinuation-in-patients-with-sle monthly 0.9 2024-02-23T09:21:00.000Z https://lupushub.com/medical-information/factors-underlying-higher-prevalence-of-systemic-lupus-erythematosus-in-females monthly 0.9 2024-02-19T17:22:00.000Z https://lupushub.com/medical-information/benefit-vs-risk-for-covid-19-vaccination-in-patients-with-systemic-lupus-erythematosus monthly 0.9 2024-02-15T03:57:00.000Z https://lupushub.com/medical-information/visual-abstract-or-safety-and-efficacy-of-telitacicept-in-patients-with-sle-results-from-a-phase-iib-trial monthly 0.9 2024-02-12T11:51:00.000Z https://lupushub.com/medical-information/neuropsychiatric-manifestations-in-early-vs-late-onset-sle-a-systematic-review-and-meta-analysis monthly 0.9 2024-02-05T08:48:00.000Z https://lupushub.com/medical-information/novel-urinary-biomarkers-for-determining-active-renal-involvement-in-systemic-lupus-erythematosus monthly 0.9 2024-02-02T15:44:00.000Z https://lupushub.com/medical-information/physician-global-assessment-for-type-2-manifestations-of-systemic-lupus-erythematosus monthly 0.9 2024-02-01T06:11:00.000Z https://lupushub.com/medical-information/case-series-telitacicept-in-patients-with-sle-and-ln-after-suboptimal-response-to-belimumab monthly 0.9 2024-01-30T08:40:00.000Z https://lupushub.com/medical-information/management-of-lupus-nephritis-kdigo-2024-clinical-practice-guidelines monthly 0.9 2026-01-12T16:30:00.000Z https://lupushub.com/medical-information/long-term-benefit-of-anifrolumab-in-sle-post-hoc-analyses-of-phase-iii-tulip-lte monthly 0.9 2024-01-16T15:16:00.000Z https://lupushub.com/medical-information/link-between-severe-non-adherence-to-hydroxychloroquine-and-sle-flares-slicc-cohort-study monthly 0.9 2024-01-11T13:20:00.000Z https://lupushub.com/medical-information/anti-dsdna-autoantibodies-in-the-diagnosis-and-management-of-sle-recommendations-by-an-expert-panel monthly 0.9 2026-01-12T16:29:00.000Z https://lupushub.com/medical-information/ianalumab-in-patients-with-systemic-lupus-erythematosus-interim-results-of-a-phase-ii-trial monthly 0.9 2024-01-16T15:23:00.000Z https://lupushub.com/medical-information/considerations-for-family-planning-in-female-patients-with-lupus monthly 0.9 2024-03-07T07:58:00.000Z https://lupushub.com/medical-information/visual-abstract-or-obinutuzumab-in-patients-with-ln-post-hoc-analyses-of-the-phase-ii-nobility-trial monthly 0.9 2023-12-27T06:39:00.000Z https://lupushub.com/medical-information/post-hoc-analyses-of-phase-ii-paisley-trial-in-patients-with-sle-treated-with-deucravacitinib monthly 0.9 2023-12-20T11:15:00.000Z https://lupushub.com/medical-information/post-hoc-analyses-of-pooled-data-from-five-phase-iii-trials-of-belimumab monthly 0.9 2023-12-20T11:21:00.000Z https://lupushub.com/medical-information/overview-of-car-t-cell-therapy-in-the-management-of-systemic-lupus-erythematosus monthly 0.9 2025-03-28T14:48:00.000Z https://lupushub.com/medical-information/current-challenges-in-the-management-of-systemic-lupus-erythematosus monthly 0.9 2023-12-11T12:31:00.000Z https://lupushub.com/medical-information/biologics-in-the-management-of-systemic-lupus-erythematosus-pooled-efficacy-and-safety monthly 0.9 2023-12-05T15:18:00.000Z https://lupushub.com/medical-information/how-might-telitacicept-fit-into-the-existing-treatment-landscape-for-patients-with-sle monthly 0.9 2025-08-19T14:43:00.000Z https://lupushub.com/medical-information/systemic-lupus-erythematosus-an-overview monthly 0.9 2024-03-07T07:56:00.000Z https://lupushub.com/medical-information/what-are-the-key-considerations-when-managing-comorbidities-and-infections-in-patients-with-sle monthly 0.9 2025-08-19T14:43:00.000Z https://lupushub.com/medical-information/belimumab-for-the-treatment-of-refractory-lupus-nephritis-real-word-experience-from-three-clinical-cases monthly 0.9 2024-04-24T08:09:00.000Z https://lupushub.com/medical-information/anifrolumab-treatment-in-adolescents-with-recalcitrant-discoid-lupus-erythematosus-a-case-series monthly 0.9 2023-11-17T14:32:00.000Z https://lupushub.com/medical-information/systematic-review-and-meta-analysis-on-efficacy-and-safety-of-jak-inhibitors-in-patients-with-scle monthly 0.9 2023-11-14T15:47:00.000Z https://lupushub.com/medical-information/management-of-systemic-lupus-erythematosus-and-lupus-nephritis-updated-2023-recommendations-from-eular monthly 0.9 2026-01-12T16:28:00.000Z https://lupushub.com/medical-information/acr-convergence-2023-abstracts-what-s-hot-in-systemic-lupus-erythematosus-and-lupus-nephritis monthly 0.9 2023-11-02T15:35:00.000Z https://lupushub.com/medical-information/editorial-theme-has-the-bimodal-mortality-pattern-of-sle-evolved-in-recent-years monthly 0.9 2023-11-07T16:06:00.000Z https://lupushub.com/medical-information/editorial-theme-or-risk-factors-for-and-prevention-of-organ-damage-accrual-in-patients-with-sle monthly 0.9 2023-10-25T12:23:00.000Z https://lupushub.com/medical-information/efficacy-and-safety-of-baricitinib-in-patients-with-sle-pooled-meta-analysis-of-rcts monthly 0.9 2023-10-11T12:22:00.000Z https://lupushub.com/medical-information/visual-abstract-or-efficacy-of-belimumab-on-renal-outcomes-post-hoc-analyses-from-phase-iii-bliss-ln-trial monthly 0.9 2023-10-09T10:34:00.000Z https://lupushub.com/medical-information/an-overview-of-risk-factors-and-strategies-for-managing-pregnancy-in-women-with-systemic-lupus-erythematosus monthly 0.9 2024-07-30T14:15:00.000Z https://lupushub.com/medical-information/dendritic-cell-immunotherapy-a-novel-approach-for-treating-systemic-lupus-erythematosus monthly 0.9 2023-09-26T08:55:00.000Z https://lupushub.com/medical-information/visual-abstract-or-efficacy-and-safety-of-obexelimab-in-sle-results-from-a-phase-ii-study monthly 0.9 2024-07-30T12:48:00.000Z https://lupushub.com/medical-information/non-pharmacological-management-of-patients-with-systemic-lupus-erythematosus-eular-recommendations monthly 0.9 2026-01-12T16:37:00.000Z https://lupushub.com/medical-information/immunosuppressive-treatment-patterns-in-patients-with-ln-a-real-world-study-from-the-united-states monthly 0.9 2023-09-11T11:59:00.000Z https://lupushub.com/medical-information/network-meta-analysis-comparing-the-efficacy-and-safety-of-maintenance-therapies-for-ln monthly 0.9 2023-09-04T09:57:00.000Z https://lupushub.com/medical-information/editorial-theme-or-patient-reported-outcome-measures-in-sle monthly 0.9 2024-07-30T12:54:00.000Z https://lupushub.com/medical-information/visual-abstract-or-comparative-risk-of-infection-in-patients-with-sle-treated-with-belimumab-versus-oral-immunosuppressants monthly 0.9 2023-08-16T10:40:00.000Z https://lupushub.com/medical-information/association-between-gut-microbiota-community-resilience-and-lupus-flares-in-patients-with-sle monthly 0.9 2023-08-02T13:03:00.000Z https://lupushub.com/medical-information/identifying-unmet-needs-in-european-patients-with-lupus-nephritis monthly 0.9 2023-08-10T12:56:00.000Z https://lupushub.com/medical-information/outcome-measures-in-sle-the-current-landscape-and-future-perspectives monthly 0.9 2024-07-30T12:54:00.000Z https://lupushub.com/medical-information/risk-factors-associated-with-cardiovascular-events-in-systemic-lupus-erythematosus monthly 0.9 2023-07-18T11:45:00.000Z https://lupushub.com/medical-information/efficacy-and-safety-of-telitacicept-in-patients-with-sle-results-from-a-phase-iii-trial monthly 0.9 2023-07-17T12:03:00.000Z https://lupushub.com/medical-information/dapirolizumab-pegol-efficacy-by-subgroup-in-patients-with-sle-post-hoc-analyses-of-the-phase-iib-rise-study monthly 0.9 2023-07-10T13:59:00.000Z https://lupushub.com/medical-information/impact-of-belimumab-on-renal-and-neuropsychiatric-flares-in-patients-with-sle-and-ln monthly 0.9 2023-06-29T14:24:00.000Z https://lupushub.com/medical-information/agreement-between-2021-definition-of-remission-in-sle-doris-and-physician-judged-remission monthly 0.9 2024-07-30T12:54:00.000Z https://lupushub.com/medical-information/eular-2023 monthly 0.9 2023-05-31T08:48:00.000Z https://lupushub.com/medical-information/editorial-theme-or-lldas-versus-remission-as-treat-to-target-goals monthly 0.9 2025-08-19T14:44:00.000Z https://lupushub.com/medical-information/how-might-deucravacitinib-fit-into-the-treatment-pathway-for-patients-with-sle monthly 0.9 2025-08-19T14:40:00.000Z https://lupushub.com/medical-information/baricitinib-in-sle-results-from-the-phase-iii-sle-brave-trials monthly 0.9 2023-05-09T12:02:00.000Z https://lupushub.com/medical-information/editorial-theme-treat-to-target-in-sle monthly 0.9 2024-07-30T12:55:00.000Z https://lupushub.com/medical-information/impact-of-medium-to-high-glucocorticoid-dose-on-the-risk-of-bloodstream-infections-in-patients-with-sle monthly 0.9 2023-04-18T08:52:00.000Z https://lupushub.com/medical-information/predictors-of-flare-in-sle monthly 0.9 2023-04-05T15:48:00.000Z https://lupushub.com/medical-information/using-the-eularacr-criteria-to-assess-organ-damage-in-patients-with-sle-and-ln monthly 0.9 2023-03-30T09:50:00.000Z https://lupushub.com/medical-information/what-do-hcps-need-to-know-about-ln-and-the-prevention-of-progression-to-esrd monthly 0.9 2023-03-27T08:05:00.000Z https://lupushub.com/medical-information/aad-2023 monthly 0.9 2023-03-22T12:39:00.000Z https://lupushub.com/medical-information/key-communications-on-lupus-at-acr-2022 monthly 0.9 2023-03-01T09:12:00.000Z https://lupushub.com/medical-information/trajectories-of-depressive-symptoms-in-sle monthly 0.9 2024-07-30T12:55:00.000Z https://lupushub.com/medical-information/incidence-of-serious-infections-in-patients-with-sle monthly 0.9 2023-02-20T09:50:00.000Z https://lupushub.com/medical-information/assessing-laboratory-markers-as-biomarkers-for-renal-flare-in-patients-with-sle monthly 0.9 2023-02-08T16:10:00.000Z https://lupushub.com/medical-information/editorial-theme-impact-of-sle-and-ln-on-patients-qol-and-body-image monthly 0.9 2024-07-30T12:56:00.000Z https://lupushub.com/medical-information/long-term-voclosporin-use-in-lupus-nephritis-results-from-aurora-2 monthly 0.9 2023-01-23T17:33:00.000Z https://lupushub.com/medical-information/the-tulip-extension-trial-of-anifrolumab-in-sle-3-year-results monthly 0.9 2023-01-20T10:14:00.000Z https://lupushub.com/medical-information/deucravacitinib-in-patients-with-sle-results-from-the-phase-ii-paisley-trial monthly 0.9 2023-01-18T12:30:00.000Z https://lupushub.com/medical-information/alternative-biomarkers-for-assessing-response-to-treatment-in-patients-with-ln monthly 0.9 2023-01-04T16:57:00.000Z https://lupushub.com/medical-information/hcq-dose-and-risk-of-hospitalization-in-patients-with-sle monthly 0.9 2022-12-20T16:34:00.000Z https://lupushub.com/medical-information/eular-recommendations-for-infection-prevention-and-vaccination-administration-in-adult-patients-with-aiird monthly 0.9 2026-01-12T16:31:00.000Z https://lupushub.com/medical-information/sle-disease-activity-at-conception-during-pregnancy-and-after-birth monthly 0.9 2022-12-13T13:44:00.000Z https://lupushub.com/medical-information/what-do-hcps-need-to-know-about-neonatal-lupus monthly 0.9 2022-12-09T11:43:00.000Z https://lupushub.com/medical-information/aplar-congress-2022 monthly 0.9 2022-12-07T09:32:00.000Z https://lupushub.com/medical-information/zetomipzomib-a-first-in-class-immunoproteasome-inhibitor-for-the-treatment-of-sle-and-ln monthly 0.9 2022-12-05T12:37:00.000Z https://lupushub.com/medical-information/the-association-of-race-and-ethnicity-with-covid19-outcomes-in-patients-with-sle monthly 0.9 2023-01-06T16:01:00.000Z https://lupushub.com/medical-information/association-between-glucocorticoids-and-chronic-damage-accrual-in-patients-with-sle monthly 0.9 2022-11-11T14:56:00.000Z https://lupushub.com/medical-information/acr-convergence-2022 monthly 0.9 2022-11-14T11:52:00.000Z https://lupushub.com/medical-information/links-between-cardiovascular-disease-and-autoimmune-disease-results-from-a-large-scale-observational-study monthly 0.9 2022-11-10T15:34:00.000Z https://lupushub.com/medical-information/editorial-theme-or-health-related-quality-of-life-in-adolescent-onset-and-adult-onset-sle monthly 0.9 2024-07-30T12:56:00.000Z https://lupushub.com/medical-information/efficacy-and-safety-of-anti-cd19-car-t-cell-therapy-in-patients-with-refractory-systemic-lupus-erythematosus monthly 0.9 2022-10-13T14:13:00.000Z https://lupushub.com/medical-information/sleuro-congress-2022 monthly 0.9 2022-10-31T14:29:00.000Z https://lupushub.com/medical-information/racial-differences-in-cvd-risk-in-patients-with-systemic-lupus-erythematosus monthly 0.9 2022-11-01T11:19:00.000Z https://lupushub.com/medical-information/differences-in-organ-damage-accrual-between-african-american-and-caucasian-patients-with-sle monthly 0.9 2022-10-04T17:29:00.000Z https://lupushub.com/medical-information/litifilimab-in-patients-with-cutaneous-lupus-erythematosus monthly 0.9 2022-11-30T17:31:00.000Z https://lupushub.com/medical-information/iberdomide-in-systemic-lupus-erythematosus-results-from-a-phase-ii-study monthly 0.9 2022-10-05T08:19:00.000Z https://lupushub.com/medical-information/tacrolimus-versus-iv-cyclophosphamide-in-patients-with-lupus-nephritis monthly 0.9 2024-07-30T12:48:00.000Z https://lupushub.com/medical-information/a-summary-of-a-prospective-cohort-study-that-compared-the-effects-of-attaining-lldas-in-patients-with-newly-diagnosed-sle-versus-established-sle monthly 0.9 2022-10-05T08:20:00.000Z https://lupushub.com/medical-information/clinical-considerations-in-the-diagnosis-and-management-of-systemic-lupus-erythematosus monthly 0.9 2022-10-10T15:17:00.000Z https://lupushub.com/medical-information/management-of-general-systemic-lupus-erythematosus monthly 0.9 2022-09-27T09:41:00.000Z https://lupushub.com/medical-information/management-of-lupus-nephritis monthly 0.9 2023-01-17T09:30:00.000Z https://lupushub.com/about-us/louise-niven monthly 0.6 2026-03-10T10:38:00.000Z https://lupushub.com/about-us/helen-croxall monthly 0.6 2026-03-10T10:38:00.000Z https://lupushub.com/about-us/jen-wilkinson monthly 0.6 2026-03-10T10:38:00.000Z https://lupushub.com/about-us/amelia-campbell-warner monthly 0.6 2026-03-10T10:38:00.000Z https://lupushub.com/about-us/haimanti-mandal monthly 0.6 2026-02-25T14:54:00.000Z https://lupushub.com/about-us/jennifer-higgins monthly 0.6 2026-02-25T14:54:00.000Z https://lupushub.com/about-us/beth-campbell monthly 0.6 2026-03-10T10:38:00.000Z https://lupushub.com/about-us/dylan-barrett monthly 0.6 2026-03-10T10:38:00.000Z https://lupushub.com/about-us/sari-cumming monthly 0.6 2026-03-10T10:38:00.000Z https://lupushub.com/about-us/devon-else monthly 0.6 2026-02-25T14:54:00.000Z https://lupushub.com/about-us/nathan-fisher monthly 0.6 2026-02-25T14:54:00.000Z https://lupushub.com/about-us/amy-hopkins monthly 0.6 2026-02-25T14:54:00.000Z https://lupushub.com/about-us/becky-gribbell monthly 0.6 2026-03-20T13:10:00.000Z https://lupushub.com/about-us/natasha-fort monthly 0.6 2026-02-25T14:54:00.000Z https://lupushub.com/about-us/addy-dallaghan monthly 0.6 2026-02-25T14:54:00.000Z https://lupushub.com/about-us/alison-roddam monthly 0.6 2026-02-25T14:54:00.000Z https://lupushub.com/about-us/monty-morris monthly 0.6 2026-04-02T14:41:00.000Z https://lupushub.com/about-us/abbie-mckillop monthly 0.6 2026-04-02T14:41:00.000Z https://lupushub.com/about-us/nathalie-tipler monthly 0.6 2026-04-02T14:41:00.000Z https://lupushub.com/about-us/suzanna-de-barra monthly 0.6 2026-04-02T14:41:00.000Z https://lupushub.com/about-us/chris-barnes monthly 0.6 2026-04-02T14:41:00.000Z https://lupushub.com/contributors/ricard-cervera monthly 0.6 2025-04-22T15:50:00.000Z https://lupushub.com/contributors/murray-urowitz monthly 0.6 2025-04-22T15:50:00.000Z https://lupushub.com/contributors/manuel-francisco-ugarte-gil monthly 0.6 2025-04-22T15:50:00.000Z https://lupushub.com/contributors/mandana-nikpour monthly 0.6 2025-04-22T15:50:00.000Z https://lupushub.com/contributors/betty-diamond monthly 0.6 2025-04-22T15:50:00.000Z https://lupushub.com/contributors/laurent-arnaud monthly 0.6 2025-04-22T15:50:00.000Z https://lupushub.com/contributors/james-cheng-chung-wei monthly 0.6 2025-05-02T08:40:00.000Z https://lupushub.com/contributors/dr monthly 0.6 2025-05-02T08:40:00.000Z https://lupushub.com/contributors/jill-buyon monthly 0.6 2025-05-02T08:40:00.000Z https://lupushub.com/contributors/gaurav-gulati monthly 0.6 2025-05-02T08:40:00.000Z https://lupushub.com/steering-committees monthly 0.7 2026-04-03T17:37:57.638Z https://lupushub.com/about-us monthly 0.7 2026-04-03T17:37:57.638Z https://lupushub.com/newsletter monthly 0.7 2026-04-03T17:37:57.638Z https://lupushub.com/our-hubs monthly 0.7 2026-04-03T17:37:57.638Z https://lupushub.com/contact monthly 0.7 2026-04-03T17:37:57.638Z